All updated as on -
The bioprocess containers industry is expected to expand from an initial valuation of $1.96B in 2023 to a total value of $10.21B in 2031, with a CAGR (compound annual growth rate) of 27% from 2024 to 2031. A decrease in the possibility of cross-contamination and an increase in the demand for biological products are the main factors boosting the industry.
The worldwide market is expected to be driven by interest in biologics and biosimilars throughout the projected period. The shift toward single-use technology is also increasing market size because it shortens production timelines. The increasing trend of laboratory service privatization is another key element propelling the global bioprocess containers market. Bioprocess containers are in high demand because to the rising number of patients undergoing immunotherapy and chemotherapy, as well as the rising number of cases of cancer and immunological disorders globally. These factors are driving the market's expansion. Consequently, the expected expansion of the market under research is driven by the rising cancer burden and investments in pharmaceutical development. It is simple to incorporate bioprocess containers into the production of various high-performance systems.
When dealing with sterile liquids, it is common practice to employ bioprocess containers, which are pliable, one-time use containers. The pharmaceutical sector employs these containers extensively for the production of vaccines and the creation of media. With features including ports, plastic films, tubing, and more, these containers are budget-friendly. Their primary use is to facilitate the rapid processing and storage of large quantities of sterile fluids. In addition to drug discovery and cell cultures, these containers find extensive use in the pharmaceutical, agro-industrial, consumer health, coatings and composites, and other related fields. The bioprocess container market is anticipated to experience growth due to the anticipated expansion of several industries, including pharmaceuticals and consumer health.
The bioprocess containers market is anticipated to experience growth because to the increasing demand for biologics. With the advent of new biologics and their many potential uses, the biologics sector is rapidly expanding within the pharmaceutical industry, which bodes well for the future of the market. Also, to meet the demand from an expanding population, vaccine production needs to be ramped up worldwide. The bioprocess containers market is anticipated to have rapid expansion in the next years, driven by factors such as the decreasing prevalence of cross-contamination and the rising popularity of single-use technology, which is driven by affordability and cost-effectiveness. On the other hand, exciting new potential for global industry growth are anticipated as biologics patents expire.
The increasing demand for more efficient, less expensive, and quicker biologics production has led to the proliferation of single-use technology. Due to the high level of sterility required in the production of patient-specific cellular and gene therapies, therapeutic vaccines, and other individualized biologics and personalized medications, single-use equipment and consumables are utilized throughout the development process. Vaccine demand skyrocketed due to the COVID-19 pandemic. A number of associated consumables, including bioprocess containers, media bags, filter assemblies, and single-use bioreactors, have seen an uptick in demand due to the epidemic.
Reduced process validation requirements and more manufacturing flexibility are two of the several benefits of single-use systems (SUS) over traditional bio-manufacturing technologies. These factors lead to improved operational efficiency and lower manufacturing costs. Despite these benefits, a big issue is that the plastic materials used for SUS could compromise the processing fluid or the final medicinal product by releasing organic or inorganic chemicals. The bioprocessing and, by extension, the medication product's safety, quality, and purity, can be jeopardized by such an undesirable alteration.
Leachables are substances found in drug products as a result of leaching from containers, closures, and processing components, whereas extractables are molecules that may be extracted from source materials using suitable solvents under rigorous laboratory conditions. There is a subset of extractables that includes leachables. Polymeric and elastomeric materials often have extractables and leachables because they require additives to make them more stable and to help create their components.
At present, the oncology pharmacology market is almost entirely dominated by biologics. By the year 2024, nearly twenty biologic patents related to cancer will have expired. Delays in the launch of biosimilars are anticipated due to the expiration of biologic patents. The need for bioprocess containers is predicted to rise due to the use of disposable systems in the production of biosimilars. The market's CAGR is so driven.
Report Coverage
Global Bioprocess Containers research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Bioprocess Containers report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Bioprocess Containers competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Bioprocess Containers market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Bioprocess Containers market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Bioprocess Containers market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Healthcare (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Sartorius (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Rim Bio (US), Fluids Control (Argentina), and Meissner (US)
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Bioprocess Containers market based on the below-mentioned segments:
Global Bioprocess Containers Market, By Type
Foam Dressings
Film Dressings
Hydrocolloid Dressings
CHG Adhesive Dressings
Alginate Dressing
Surgical Tapes
Hydrogel Dressings
Others
Global Bioprocess Containers market, By Application
Diabetic Foot Ulcers
Pressure Ulcers
Surgical and Traumatic Wounds
Burns
Ostomy Care
Others
Global Bioprocess Containers Market, By End User
Hospitals and Clinics
Home Care Settings
Others
Global Bioprocess Containers market, Regional Analysis
The worldwide market is expected to be driven by interest in biologics and biosimilars throughout the projected period. The shift toward single-use technology is also increasing market size because it shortens production timelines. The increasing trend of laboratory service privatization is another key element propelling the global bioprocess containers market. Bioprocess containers are in high demand because to the rising number of patients undergoing immunotherapy and chemotherapy, as well as the rising number of cases of cancer and immunological disorders globally. These factors are driving the market's expansion. Consequently, the expected expansion of the market under research is driven by the rising cancer burden and investments in pharmaceutical development. It is simple to incorporate bioprocess containers into the production of various high-performance systems.
When dealing with sterile liquids, it is common practice to employ bioprocess containers, which are pliable, one-time use containers. The pharmaceutical sector employs these containers extensively for the production of vaccines and the creation of media. With features including ports, plastic films, tubing, and more, these containers are budget-friendly. Their primary use is to facilitate the rapid processing and storage of large quantities of sterile fluids. In addition to drug discovery and cell cultures, these containers find extensive use in the pharmaceutical, agro-industrial, consumer health, coatings and composites, and other related fields. The bioprocess container market is anticipated to experience growth due to the anticipated expansion of several industries, including pharmaceuticals and consumer health.
The bioprocess containers market is anticipated to experience growth because to the increasing demand for biologics. With the advent of new biologics and their many potential uses, the biologics sector is rapidly expanding within the pharmaceutical industry, which bodes well for the future of the market. Also, to meet the demand from an expanding population, vaccine production needs to be ramped up worldwide. The bioprocess containers market is anticipated to have rapid expansion in the next years, driven by factors such as the decreasing prevalence of cross-contamination and the rising popularity of single-use technology, which is driven by affordability and cost-effectiveness. On the other hand, exciting new potential for global industry growth are anticipated as biologics patents expire.
The increasing demand for more efficient, less expensive, and quicker biologics production has led to the proliferation of single-use technology. Due to the high level of sterility required in the production of patient-specific cellular and gene therapies, therapeutic vaccines, and other individualized biologics and personalized medications, single-use equipment and consumables are utilized throughout the development process. Vaccine demand skyrocketed due to the COVID-19 pandemic. A number of associated consumables, including bioprocess containers, media bags, filter assemblies, and single-use bioreactors, have seen an uptick in demand due to the epidemic.
Reduced process validation requirements and more manufacturing flexibility are two of the several benefits of single-use systems (SUS) over traditional bio-manufacturing technologies. These factors lead to improved operational efficiency and lower manufacturing costs. Despite these benefits, a big issue is that the plastic materials used for SUS could compromise the processing fluid or the final medicinal product by releasing organic or inorganic chemicals. The bioprocessing and, by extension, the medication product's safety, quality, and purity, can be jeopardized by such an undesirable alteration.
Leachables are substances found in drug products as a result of leaching from containers, closures, and processing components, whereas extractables are molecules that may be extracted from source materials using suitable solvents under rigorous laboratory conditions. There is a subset of extractables that includes leachables. Polymeric and elastomeric materials often have extractables and leachables because they require additives to make them more stable and to help create their components.
At present, the oncology pharmacology market is almost entirely dominated by biologics. By the year 2024, nearly twenty biologic patents related to cancer will have expired. Delays in the launch of biosimilars are anticipated due to the expiration of biologic patents. The need for bioprocess containers is predicted to rise due to the use of disposable systems in the production of biosimilars. The market's CAGR is so driven.
Report Coverage
Global Bioprocess Containers research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Bioprocess Containers report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Bioprocess Containers competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Bioprocess Containers market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Healthcare (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Sartorius (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Rim Bio (US), Fluids Control (Argentina), and Meissner (US) |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Bioprocess Containers Market from 2021 to 2031.
- Market Forecast for Bioprocess Containers Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Bioprocess Containers competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Bioprocess Containers
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Bioprocess Containers market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Bioprocess Containers market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Healthcare (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Sartorius (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Rim Bio (US), Fluids Control (Argentina), and Meissner (US)
Primary Target Market
- Market Players of Bioprocess Containers
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Bioprocess Containers market based on the below-mentioned segments:
Global Bioprocess Containers Market, By Type
Foam Dressings
Film Dressings
Hydrocolloid Dressings
CHG Adhesive Dressings
Alginate Dressing
Surgical Tapes
Hydrogel Dressings
Others
Global Bioprocess Containers market, By Application
Diabetic Foot Ulcers
Pressure Ulcers
Surgical and Traumatic Wounds
Burns
Ostomy Care
Others
Global Bioprocess Containers Market, By End User
Hospitals and Clinics
Home Care Settings
Others
Global Bioprocess Containers market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive bioprocess containers market market research and competitor analysis for your business to help you develop more profound insights into the bioprocess containers market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the bioprocess containers market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.